Cargando…
Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management
Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over 220 countries and territories have been affected by this virus, and the infection rate has continued to rise. As patients recover from the virus, many are experiencing lingering sympto...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977184/ https://www.ncbi.nlm.nih.gov/pubmed/35402784 http://dx.doi.org/10.1007/s42399-022-01167-4 |
_version_ | 1784680714563747840 |
---|---|
author | Munipalli, Bala Seim, Lynsey Dawson, Nancy L. Knight, Dacre Dabrh, Abd Moain Abu |
author_facet | Munipalli, Bala Seim, Lynsey Dawson, Nancy L. Knight, Dacre Dabrh, Abd Moain Abu |
author_sort | Munipalli, Bala |
collection | PubMed |
description | Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over 220 countries and territories have been affected by this virus, and the infection rate has continued to rise. As patients recover from the virus, many are experiencing lingering symptoms. Understanding the impact of demographics and comorbidities on symptom prevalence, manifestations, and severity is not only relevant during acute infection, it is critical to the clinical management of patients with post-acute sequelae of COVID-19, also known as PASC. Herein, we provide a comprehensive review on the most recent research related to PASC. Specifically, we focus on the description of the disorder itself, compared to acute COVID-19, and which types of patients are most affected by long-term sequelae. Further, we share recommendations for management of the most common complications of PASC. |
format | Online Article Text |
id | pubmed-8977184 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-89771842022-04-04 Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management Munipalli, Bala Seim, Lynsey Dawson, Nancy L. Knight, Dacre Dabrh, Abd Moain Abu SN Compr Clin Med Review Coronavirus Disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Over 220 countries and territories have been affected by this virus, and the infection rate has continued to rise. As patients recover from the virus, many are experiencing lingering symptoms. Understanding the impact of demographics and comorbidities on symptom prevalence, manifestations, and severity is not only relevant during acute infection, it is critical to the clinical management of patients with post-acute sequelae of COVID-19, also known as PASC. Herein, we provide a comprehensive review on the most recent research related to PASC. Specifically, we focus on the description of the disorder itself, compared to acute COVID-19, and which types of patients are most affected by long-term sequelae. Further, we share recommendations for management of the most common complications of PASC. Springer International Publishing 2022-04-04 2022 /pmc/articles/PMC8977184/ /pubmed/35402784 http://dx.doi.org/10.1007/s42399-022-01167-4 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Review Munipalli, Bala Seim, Lynsey Dawson, Nancy L. Knight, Dacre Dabrh, Abd Moain Abu Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management |
title | Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management |
title_full | Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management |
title_fullStr | Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management |
title_full_unstemmed | Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management |
title_short | Post-acute sequelae of COVID-19 (PASC): a meta-narrative review of pathophysiology, prevalence, and management |
title_sort | post-acute sequelae of covid-19 (pasc): a meta-narrative review of pathophysiology, prevalence, and management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977184/ https://www.ncbi.nlm.nih.gov/pubmed/35402784 http://dx.doi.org/10.1007/s42399-022-01167-4 |
work_keys_str_mv | AT munipallibala postacutesequelaeofcovid19pascametanarrativereviewofpathophysiologyprevalenceandmanagement AT seimlynsey postacutesequelaeofcovid19pascametanarrativereviewofpathophysiologyprevalenceandmanagement AT dawsonnancyl postacutesequelaeofcovid19pascametanarrativereviewofpathophysiologyprevalenceandmanagement AT knightdacre postacutesequelaeofcovid19pascametanarrativereviewofpathophysiologyprevalenceandmanagement AT dabrhabdmoainabu postacutesequelaeofcovid19pascametanarrativereviewofpathophysiologyprevalenceandmanagement |